EDGAR Filing Documents for 0001193125-19-314292

Form SC TO-T - Tender offer statement by Third Party:

SEC Accession No. 0001193125-19-314292

Filing Date

2019-12-16

Accepted

2019-12-16 06:10:30

Documents

Group Members

ASILOMAR ACQUISITION CORP.

Document Format Files

Seq	Description	Document	Type	Size
1	SC TO-T	d837696dsctot.htm	SC TO-T	71454
2	EXHIBIT (A)(1)(A)	d837696dex99a1a.htm	EX-99.(A)(1)(A)	504636
3	EXHIBIT (A)(1)(B)	d837696dex99a1b.htm	EX-99.(A)(1)(B)	228388
4	EXHIBIT (A)(1)(C)	d837696dex99a1c.htm	EX-99.(A)(1)(C)	13670
5	EXHIBIT (A)(1)(D)	d837696dex99a1d.htm	EX-99.(A)(1)(D)	24648
6	EXHIBIT (A)(1)(K)	d837696dex99a1k.htm	EX-99.(A)(1)(K)	23663
7	EXHIBIT (A)(1)(L)	d837696dex99a1l.htm	EX-99.(A)(1)(L)	11672
8	EX-99.(D)(2)	d837696dex99d2.htm	EX-99.(D)(2)	50102
9	GRAPHIC	g837696g01p85.jpg	GRAPHIC	55521
10	GRAPHIC	g837696sas.jpg	GRAPHIC	9597
	Complete submission text file	0001193125-19-314292.txt		1019708

Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411

Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231

Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108

Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556

Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)